121 filings
Page 4 of 7
8-K
j04cs6b7
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
8-K
nplck
5 Mar 20
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm
8-K
dmta644 hrl7pjj7t9z
5 Feb 20
Regulation FD Disclosure
4:30pm
8-K
5gw1 t28vf28vs
13 Jan 20
Regulation FD Disclosure
7:17am
8-K
pig38nfbg0w3yj
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
tg2ppgf qjxha
6 Nov 19
Zafgen Reports Third Quarter 2019 Financial Results
4:30pm
8-K
5066n 7hlvbpqfzad7x6
19 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
r6qloq7wn4c 8h
12 Sep 19
Cost Associated with Exit or Disposal Activities
5:19pm
8-K
rf473cx7p66xz5dqjes3
8 Aug 19
Zafgen Reports Second Quarter 2019 Operating and Financial Results
4:32pm
8-K
vm440qq584w11o
13 Jun 19
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
na7j0 bgl
30 May 19
Zafgen Announces Regulatory Update onZGN-1061
7:21am
8-K
5ylw er8o
9 May 19
Zafgen Reports First Quarter 2019 Operating and Financial Results
4:26pm
8-K
mzcvhywuj0tr866zpd
4 Apr 19
Other Events
4:47pm
8-K
a1rl lea8
11 Mar 19
Results of Operations and Financial Condition
4:12pm
8-K
5832dn e6brdghfg
15 Feb 19
Entry into a Material Definitive Agreement
5:00pm
8-K
o7shz
17 Jan 19
Zafgen Announces Positive Results for Second Cohort
7:30am
8-K
v1ovyt 1sgx
26 Nov 18
Zafgen Provides Update on Investigational New Drug Application forZGN-1061
7:17am
8-K
efuau3rqbh
9 Nov 18
Entry into a Material Definitive Agreement
5:10pm
8-K
njcr8qv4rzaad7
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
8-K
gn3piry mxq
7 Aug 18
Zafgen Reports Second Quarter 2018 Operating and Financial Results
4:21pm